In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins
Prolonged remissions were induced in mice bearing advanced BCL1 tumors by the combined approach of nonspecific cytoreductive therapy and administration of a tumor-reactive immunotoxin. Thus, the vast majority of the tumor cells (approximately 95%) were first killed by nonspecific cytoreductive thera...
| Format: | Online |
|---|---|
| Language: | English |
| Published: |
The Rockefeller University Press
1982
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186702/ |